SCHEMBL43354

SCHEMBL43354

CCCNC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propane SCHEMBL31494775 0.97 MMP1 (0.48)
SCHEMBL28156347 0.97
SCHEMBL27787561 0.97 MMP1 (0.48)
Hydrochloric Acid SCHEMBL11072255 0.97
SCHEMBL27787563 0.97
Acetic Acid SCHEMBL10885571 0.94 MMP1 (0.46)
Iodomethane SCHEMBL28143094 0.94
Methoxymethane SCHEMBL6225798 0.92 MMP1 (0.44)
SCHEMBL1670176 0.92 MMP1 (0.44)
Propylamine SCHEMBL4175347 0.89 MMP1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2203 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4712948-A2 GENE EDITING SYSTEMS AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USING THE SAME Renagade Therapeutics Management Inc. (US) 2026-03-25 EP claimed
EP-3791863-B1 PROCESS FOR THE PRODUCTION OF HYBRIDOSOMES ANJARIUM BIOSCIENCES AG (CH) 2025-09-10 EP claimed
WO-2025049959-A9 GENE EDITING SYSTEMS, COMPOSITIONS, AND METHODS FOR TREATMENT OF VEXAS SYNDROME RENAGADE THERAPEUTICS MANAGEMENT INC. (US) 2025-06-12 WO claimed
WO-2025049959-A2 GENE EDITING SYSTEMS, COMPOSITIONS, AND METHODS FOR TREATMENT OF VEXAS SYNDROME RENAGADE THERAPEUTICS MANAGEMENT INC. (US) 2025-03-06 WO claimed
WO-2024238828-A2 GENE EDITING SYSTEMS AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USING THE SAME RENAGADE THERAPEUTICS MANAGEMENT INC. (US) 2024-11-21 WO claimed
US-20240199607-A1 BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY ASTEX THERAPEUTICS LIMITED (GB) 2024-06-20 US claimed
CN-118165028-A Preparation method of isocyanate modified silane coupling agent 万华化学集团股份有限公司 2024-06-11 CN claimed
US-20240059926-A1 COATING COMPOSITION COMPRISING A CARBAMATE-FUNCTIONAL POLY(ETHYLENE-ACRYLATE) COPOLYMER AND METHOD OF COATING SUBSTRATES BASF COATINGS GMBH (DE) 2024-02-22 US claimed
US-11866428-B2 Bicyclic heterocycle compounds and their uses in therapy ASTEX THERAPEUTICS LIMITED (GB) 2024-01-09 US claimed
CN-116370437-A Nucleic acid lipid nanoparticle compositions comprising cholesterol succinic acid monoesters and uses thereof 北京因诺惟康医药科技有限公司 2023-07-04 CN claimed
EP-0552213-A1 1,2,5,6-TETRAHYDROPYRIDINE OXIME DERIVATIVES BEECHAM GROUP PLC (GB) 1993-07-28 EP claimed
EP-0411583-B1 AUTOGENOUSLY AIR-SETTING MORTAR SYREMONT S.p.A. (IT) 1993-06-16 EP claimed
US-5137936-A Method for packaging electronic parts and adhesive for use in said method MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1992-08-11 US claimed
EP-0322351-B1 FUNGICIDAL COMPOSITION WITH SYNERGISTIC ACTIVITY SCHERING AKTIENGESELLSCHAFT (DE) 1992-08-05 EP claimed
WO-1992006959-A1 1,2,5,6-TETRAHYDROPYRIDINE OXIME DERIVATIVES BEECHAM GROUP PLC (GB) 1992-04-30 WO claimed
EP-0411583-A1 Autogenously air-setting mortar SYREMONT S.p.A. (IT) 1991-02-06 EP claimed
EP-0193926-B1 PHENYL CARBAMATES PROTERRA AG (CH) 1990-11-07 EP claimed
EP-0310622-A1 ANTI-INFLAMMATORY COMPOSITIONS. ALDER RES CENTER CORP (US) 1989-04-12 EP claimed
WO-1987007599-A2 ANTI-INFLAMMATORY COMPOSITIONS ALDER RESEARCH CENTER CORPORATION (US) 1987-12-17 WO claimed
US-4226883-A Carbamate derivatives and method for manufacture thereof YAMAMOTO IZURU 1980-10-07 US claimed